Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC
for Breast Cancer
15 locations incl. Stamford
Sponsor: Dana-Farber Cancer Institute
Sex: All·Age: 18+
Code: NCT04468061·Phase 2·Recruiting·Listed Jul 2020
DFCI @ Foxborough
Clinical research site in Foxborough, Massachusetts · 10 LINCOLN RD, STE 101, FOXBOROUGH, MA 02035-1382 · (774) 215-5696
As of July 2026, 1 paid clinical trial is recruiting at DFCI @ Foxborough in Foxborough, Massachusetts. Active studies at this site cover conditions such as Breast Cancer, PD-L1 Negative and Triple Negative Breast Cancer. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Recruiting clinical trials at DFCI @ Foxborough (1)
More research sites in Foxborough
- Dana-Farber Cancer Institute at Foxborough (9 trials)
- K2 Medical Research - Foxborough (4 trials)
- Neurology Center of New England (3 trials)
- Dana-Farber Brigham Cancer Center - Foxborough (2 trials)
- Brigham and Women's Foxborough (1 trial)
- Brigham and Women's-Mass General Health Care Center (1 trial)
- Brigham and Womens/Mass General Health Care Center at Foxborough (1 trial)
- Center for Sports Performance and Research (1 trial)
- Dana Farber Cancer Institute at Foxborough (1 trial)
- Dana-Farber Brigham Cancer Center Foxborough (1 trial)
Explore more
Paid clinical trials in Foxborough, MA · Massachusetts clinical trials